Promimic

10,80 SEK

0,00%

Mindre end 1K følgere

PRO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

0,00 %
-1,82 %
-8,86 %
-36,28 %
-10,37 %
-55,56 %
-43,16 %
-
-33,67 %

Promimic specializes in biotechnology. The company develops biocompatible surfaces for implants and conducts research in surface modifications. Examples of specialist areas include surface modifications for osseointegration for orthopedic and dental implants. The largest operations are in Europe and America, where research and development is conducted in-house but also through partners. Promimic is headquartered in Mölndal, Sweden.

Læs mere
Markedsværdi
204,04 mio. SEK
Aktieomsætning
70,99 t SEK
Omsætning
44,42 mio.
EBIT %
-17,33 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
19.5
2026

Delårsrapport Q1'26

21.5
2026

Generalforsamling '26

20.8
2026

Delårsrapport Q2'26